Catalogue · United Kingdom stock
Metabolic research peptides
Metabolic research peptides — including retatrutide and cagrilintide, the triple-agonist and amylin-analogue compounds at the centre of current metabolic research. Every vial is HPLC + mass-spec verified with a batch-linked Certificate of Analysis, dispatched same-day from UK stock. Research use only.
Retatrutide is the flagship of this category — the single-molecule GLP-1 / GIP / glucagon triple agonist at the frontier of incretin research — supplied alongside the long-acting amylin analogue cagrilintide and supporting metabolic compounds. Every strength carries its own batch code and Certificate of Analysis, verifiable from the code printed on the vial.
Featured research
Research hub →6 min read
What Is Retatrutide? Research Overview
A science-led overview of retatrutide: a synthetic GLP-1 / GIP / glucagon triple agonist peptide studied in clinical research.
6 min read
Retatrutide vs Semaglutide Compared
A science-led comparison of semaglutide and retatrutide, framed around how many incretin receptors each molecule engages.
6 min read
Cagrilintide: Amylin Analogue Guide
An overview of cagrilintide, a long-acting synthetic amylin analogue, and why it is frequently studied alongside GLP-1 receptor agonists in metabolic research.